(Recognition and measurement) With regard to the cost formula of inventories, the Company  and its domestic subsidiaries were mainly using the average  method. However, the Group applied the first-in, first-out  (FIFO) method under IFRS. As a result, the amount of “Inventories” has decreased. (Presentation) Accounts receivable-other included in “Other” as current  assets under Japanese GAAP have been included in “Trade  and other receivables” under IFRS. “Allowance for doubtful accounts” presented separately in  current assets under Japanese GAAP have been included in  “Trade and other receivables” under IFRS. (Recognition and measurement) Certain provisions for sales discounts or returns have been  deducted from “Notes and accounts receivable-trade” under  Japanese GAAP. However, they have been included in  “Provisions” (current) under IFRS. As a result, the amount of  “Trade and other receivables” has increased. (Presentation) Time deposits with maturities over three months included in  “Cash and deposits” under Japanese GAAP have been  included in “Other financial assets” (current) under IFRS. Securities with maturities less than three months were  included in “Securities” as current assets under Japanese  GAAP. However, securities other than cash equivalents are  included in “Other financial assets” (current) under IFRS. Advances paid and deposits paid included in “Other” as  current assets under Japanese GAAP have been included in  “Other financial assets” (current) under IFRS. (Presentation) Accounts receivable-other included in “Other” as current  assets under Japanese GAAP have been included in “Trade  and other receivables” under IFRS. Income tax receivable included in “Other” as current assets  under Japanese GAAP has been presented separately as  “Income tax receivable” under IFRS. Advances paid and deposits paid included in “Other” as  current assets under Japanese GAAP have been included in  “Other financial assets” (current) under IFRS. (Presentation) “Subscription rights to shares” presented separately under  Japanese GAAP have been included in “Other components of  equity” under IFRS. (Recognition and measurement) The Group applied the exemption under IFRS 1 and transferred  all cumulative exchange differences on translating foreign  operations to retained earnings on the date of transition to  IFRS (1 April 2012). As a result, “Other components of equity”  has increased by ¥147,167 million. (Recognition and measurement) (Presentation) Assets held for sale included in “Property, plant and equipment,  net” under Japanese GAAP were reclassified and presented  separately as “Assets held for sale” under IFRS. Securities with maturities less than three months were  included in “Securities” as current assets under Japanese  GAAP. However, securities satisfying the classification require- ments for recognition as cash equivalents are included in  “Cash and cash equivalents” under IFRS. (Presentation) Time deposits with maturities over three months included in  “Cash and deposits” under Japanese GAAP have been  included in “Other financial assets” (current) under IFRS. L Cash and cash equivalents M Assets held for sale N Retained earnings J Other financial assets (current) I Trade and other receivables K Other current assets Astellas Pharma Inc.  _ Annual Report 2014 162 O Other components of equity As of 31 March 2013 (Millions of yen) Property, plant and equipment (refer to A) ¥ (5,662) Goodwill (refer to B) 10,318 Other intangible assets (refer to C) 141,088 Inventories (refer to H) (1,085) Foreign currency translation adjustments (refer to O) (147,167) Retirement benefit liabilities (refer to R) (13,647) Accrued paid absences (refer to Z) (4,841) Other 508 Sub total (20,488) Adjustment of tax effect (21,550) Total adjustments to retained earnings ¥ (42,039)